BUDESONIDE
Generic: BUDESONIDE
Oceanside PharmaceuticalsManufacturer
ORALRoute
BUDESONIDEActive Substance
2013-01-14Original Approval
BUDESONIDE is FDA application NDA203634, sponsored by SALIX. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2024-01-08
Budesonide Extended-Release Tablets 9mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., FortFailed Dissolution Specifications
Class II2026-05-29
Budesonide Inhalation Suspension, 1mg/2mL, 30 x 2 mL Sterile Single-Dose Ampules (5 Single-Dose Ampules per pouch, 6 pouPresence of Foreign Substance:This recall has been initiated in response to a product quality compla
Class II2025-06-30
Budesonide Inhalation Suspension, 0.5mg/2ml, 30 single-dose ampules per carton, five per pouch, RX Only, Manufactured byLack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.
Class II2022-09-15
Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Single Dose Ampules peLack of Assurance of Sterility
Class II2021-03-15
Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol 80/4.5 budesonide 80 mcg/formoterol fumarate dihydrate 4CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Top Reported Reactions
1
DRUG INEFFECTIVE
4,901 reports
2
DYSPNOEA
4,588 reports
3
OFF LABEL USE
4,448 reports
4
ASTHMA
3,637 reports
5
FATIGUE
2,608 reports
6
CONDITION AGGRAVATED
2,496 reports
7
HEADACHE
2,442 reports
8
DIARRHOEA
2,391 reports
9
COUGH
2,248 reports
10
PNEUMONIA
2,247 reports